Intellectual Property Cases
Cases 81 - 90 of 274
iCeutica Pty Ltd. et al v. Apotex, Inc. et al
as 1:2017cv01553
Plaintiff: iCeutica Pty Ltd. and Iroko Pharmaceuticals, LLC
Defendant: Apotex, Inc. and Apotex Corp.
Counter_claimant: Apotex Corp. and Apotex, Inc.
Counter_defendant: Iroko Pharmaceuticals, LLC and iCeutica Pty Ltd.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company v. Apotex Inc. et al
as 1:2017cv01493
Plaintiff: Bristol-Myers Squibb Company
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. Apotex Inc. et al
as 1:2017cv01202
Plaintiff: Onyx Therapeutics, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Apotex Inc. et al
as 1:2017cv01164
Plaintiff: Teva Pharmaceuticals International GmbH , Cephalon, Inc. and Eagle Pharmaceuticals, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME CORP. v. APOTEX INC. et al
as 3:2017cv05399
Plaintiff: MERCK SHARP & DOHME CORP.
Defendant: APOTEX INC. and APOTEX CORP.
Cause Of Action: 15 U.S.C. § 1126
Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al
as 1:2017cv00990
Plaintiff: Mitsubishi Tanabe Pharma Corporation , Janssen Pharmaceuticals Inc. , Janssen Pharmaceutica, N.V. and others
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORP. et al v. APOTEX, INC., et al
as 3:2017cv05278
Plaintiff: MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant: APOTEX, INC. and APOTEX CORP.
Cause Of Action: 15 U.S.C. § 1126
AstraZeneca LP et al. v. Apotex Inc., et al.
as 1:2017cv00714
Plaintiff: AstraZeneca LP , Astrazeneca AB , AstraZeneca UK Limited and others
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 145
CELGENE CORPORATION v. HETERO LABS LIMITED et al We have downloadable decisions or orders for this case
as 2:2017cv03387
Plaintiff: CELGENE CORPORATION
Defendant: HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED and others
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Apotex, Inc. et al
as 1:2017cv00399
Plaintiff: Bristol-Myers Squibb Company and Pfizer Inc.
Defendant: Apotex, Inc. and Apotex Corp.
Counter_claimant: Apotex Corp. and Apotex, Inc.
Counter_defendant: Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?